ImmunityBio (IBRX) Acquisitions (2015)
ImmunityBio (IBRX) reported Acquisitions of $1.8 million for Q1 2015.
ImmunityBio (IBRX) has 1 years of Acquisitions data on file, last reported at $1.8 million in Q1 2015.
- Quarterly Acquisitions changed N/A year-over-year to $1.8 million in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $1.8 million (changed N/A YoY) and the FY2024 annual result came in at $1.0 million, changed N/A from the prior year.
- Acquisitions held at $1.8 million in Q1 2015 per IBRX's latest filing.
- Across five years, Acquisitions topped out at $1.8 million in Q1 2015 and bottomed at $1.8 million in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 1.82 Mn |